Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #12,251 to #12,300.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Kim JH, et al. Sci. Rep. (2018) cited as Ref 397 in DOI: 10.1038/s41392-020-0110-5 (Q9660)‏‎ (2 links)
  2. Qiu HB, et al, Zhonghua jie he he hu xi za zhi (2020), cited as Ref 19 in DOI: 10.1186/s13054-020-02882-x (Q10650)‏‎ (2 links)
  3. Wang JC, et al. Theranostics (2019) cited as Ref 686 in DOI: 10.1038/s41392-020-0110-5 (Q9949)‏‎ (2 links)
  4. Todaro M, et al. Cell Stem Cell (2014) cited as Ref 173 in DOI: 10.1038/s41392-020-0110-5 (Q9436)‏‎ (2 links)
  5. Gwak J, et al. Int. J. Mol. Med. (2006) cited as Ref 405 in DOI: 10.1038/s41392-020-0110-5 (Q9668)‏‎ (2 links)
  6. Trzepacz PT, et al, J Neuropsychiatry Clin Neurosci (2001), cited as Ref 27 in DOI: 10.1186/s13054-020-02882-x (Q10658)‏‎ (2 links)
  7. Xue ZF, et al. J. Cell. Biochem. (2012) cited as Ref 694 in DOI: 10.1038/s41392-020-0110-5 (Q9957)‏‎ (2 links)
  8. Ranganathan P, et al. Nat. Rev. Cancer (2011) cited as Ref 181 in DOI: 10.1038/s41392-020-0110-5 (Q9444)‏‎ (2 links)
  9. Serra R, et al. J. Mammary Gland Biol. Neoplasia (2011) cited as Ref 413 in DOI: 10.1038/s41392-020-0110-5 (Q9676)‏‎ (2 links)
  10. Pandharipande PP, et al, Crit Care Med (2004), cited as Ref 35 in DOI: 10.1186/s13054-020-02882-x (Q10666)‏‎ (2 links)
  11. Lugli A, et al. Br. J. Cancer (2010) cited as Ref 702 in DOI: 10.1038/s41392-020-0110-5 (Q9965)‏‎ (2 links)
  12. Parr C, et al. Int. J. Mol. Med. (2004) cited as Ref 189 in DOI: 10.1038/s41392-020-0110-5 (Q9452)‏‎ (2 links)
  13. Scully S, et al. J. Neurosci. (2012) cited as Ref 421 in DOI: 10.1038/s41392-020-0110-5 (Q9684)‏‎ (2 links)
  14. Li YC, et al, J Comp Neurol (2013), cited as Ref 43 in DOI: 10.1186/s13054-020-02882-x (Q10674)‏‎ (2 links)
  15. Yang ZF, et al. Cancer Cell (2008) cited as Ref 710 in DOI: 10.1038/s41392-020-0110-5 (Q9973)‏‎ (2 links)
  16. Garcia-Heredia JM, et al. Clin. Cancer Res. (2017) cited as Ref 197 in DOI: 10.1038/s41392-020-0110-5 (Q9460)‏‎ (2 links)
  17. In the Southwest where medicine men are still lag. [IndianCountry/Health] (Q5999)‏‎ (2 links)
  18. JK Scott kickoff for 65 yds for a touchback (10/21/17b) (Q3086)‏‎ (2 links)
  19. tocilizumab (chemical - MeSH supplementary concept) (Q10973)‏‎ (2 links)
  20. Pezzolo A, et al. Cell Res. (2011) cited as Ref 429 in DOI: 10.1038/s41392-020-0110-5 (Q9692)‏‎ (2 links)
  21. Mengeling WL, et al, Am J Vet Res (1972), cited as Ref 51 in DOI: 10.1186/s13054-020-02882-x (Q10682)‏‎ (2 links)
  22. Maguer-Satta V, et al. Stem Cells (2011) cited as Ref 718 in DOI: 10.1038/s41392-020-0110-5 (Q9981)‏‎ (2 links)
  23. Kao SH, et al. J. Clin. Med. (2016) cited as Ref 205 in DOI: 10.1038/s41392-020-0110-5 (Q9468)‏‎ (2 links)
  24. lopinavir-ritonavir drug combination (chemical - MeSH supplementary concept) (Q10863)‏‎ (2 links)
  25. JK Scott kickoff for 63 yds Kalija Lipscomb return for 16 yds to the Vandy 18 (9/23/17)‏‎ (2 links)
  26. Gilbertson RJ, et al. Nat. Rev. Cancer (2007) cited as Ref 437 in DOI: 10.1038/s41392-020-0110-5 (Q9700)‏‎ (2 links)
  27. Baig AM, et al, ACS Chem Neurosci (2020), cited as Ref 59 in DOI: 10.1186/s13054-020-02882-x (Q10690)‏‎ (2 links)
  28. van der Horst G, et al. Mol. Cancer Res. (2012) cited as Ref 726 in DOI: 10.1038/s41392-020-0110-5 (Q9989)‏‎ (2 links)
  29. Binder M, et al. Stem Cells (2019) cited as Ref 213 in DOI: 10.1038/s41392-020-0110-5 (Q9476)‏‎ (2 links)
  30. Mendez O, et al. Mol. Cancer (2010) cited as Ref 445 in DOI: 10.1038/s41392-020-0110-5 (Q9708)‏‎ (2 links)
  31. Kim LJ, et al, Brain Res (2015), cited as Ref 67 in DOI: 10.1186/s13054-020-02882-x (Q10698)‏‎ (2 links)
  32. Kryczek I, et al. Int. J. Cancer (2012) cited as Ref 734 in DOI: 10.1038/s41392-020-0110-5 (Q9997)‏‎ (2 links)
  33. Robbins DJ, et al. Sci. Signal. (2012) cited as Ref 221 in DOI: 10.1038/s41392-020-0110-5 (Q9484)‏‎ (2 links)
  34. Brent Cimaglia kickoff for 60 yds Henry Ruggs III return for 21 yds to the Alab 41 (10-21-17)‏‎ (2 links)
  35. Sica A, et al. J. Clin. Invest (2012) cited as Ref 453 in DOI: 10.1038/s41392-020-0110-5 (Q9716)‏‎ (2 links)
  36. Girard TD, et al, Lancet Respir Med (2018), cited as Ref 75 in DOI: 10.1186/s13054-020-02882-x (Q10706)‏‎ (2 links)
  37. Louis CU, et al. Annu. Rev. Med. (2015) cited as Ref 229 in DOI: 10.1038/s41392-020-0110-5 (Q9492)‏‎ (2 links)
  38. Wu A, et al. Neuro Oncol. (2010) cited as Ref 461 in DOI: 10.1038/s41392-020-0110-5 (Q9724)‏‎ (2 links)
  39. Hsieh SJ, et al, Crit Care Med (2019), cited as Ref 83 in DOI: 10.1186/s13054-020-02882-x (Q10714)‏‎ (2 links)
  40. Imai N, et al, Imperial College London (2020) cited as Ref 3 in DOI: 10.3201/eid2605.200146 (Q11209)‏‎ (2 links)
  41. Yang L, et al. Oncogene (2010) cited as Ref 237 in DOI: 10.1038/s41392-020-0110-5 (Q9500)‏‎ (2 links)
  42. Wang H, et al. Cell Oncol. (Dordr.) (2016) cited as Ref 469 in DOI: 10.1038/s41392-020-0110-5 (Q9732)‏‎ (2 links)
  43. Pandolfi S, et al. Oncogene (2013) cited as Ref 245 in DOI: 10.1038/s41392-020-0110-5 (Q9508)‏‎ (2 links)
  44. Goicoechea SM, et al. Oncogene (2014) cited as Ref 477 in DOI: 10.1038/s41392-020-0110-5 (Q9740)‏‎ (2 links)
  45. Han B, et al. Cell Rep. (2015) cited as Ref 253 in DOI: 10.1038/s41392-020-0110-5 (Q9516)‏‎ (2 links)
  46. Chen WJ, et al. Nat. Commun. (2014) cited as Ref 485 in DOI: 10.1038/s41392-020-0110-5 (Q9748)‏‎ (2 links)
  47. Nahmias AJ, et al, Pediatr. Res. (1971), cited as Ref 5 in DOI: 10.1016/j.jcv.2020.104372 (Q10452)‏‎ (2 links)
  48. Takebe N, et al. Nat. Rev. Clin. Oncol. (2011) cited as Ref 261 in DOI: 10.1038/s41392-020-0110-5 (Q9524)‏‎ (2 links)
  49. Cavarretta IT, et al. Mol. Ther. (2010) cited as Ref 493 in DOI: 10.1038/s41392-020-0110-5 (Q9756)‏‎ (2 links)
  50. Tahotna A, et al, Interdiscip. Toxicol. (2018), cited as Ref 13 in DOI: 10.1016/j.jcv.2020.104372 (Q10460)‏‎ (2 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:MostLinkedPages"